Tilray Brands (NASDAQ:TLRY) Shares Down 2.9% – What’s Next?

Tilray Brands, Inc. (NASDAQ:TLRY) shares traded down 2.9% during mid-day trading on Thursday . The company traded as low as $7.55 and last traded at $7.62. 3,142,516 shares traded hands during trading, a decline of 46% from the average session volume of 5,787,148 shares. The stock had previously closed at $7.85.

Key Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Zacks argues TLRY has an edge over peers thanks to rising international revenue, scaled beverage operations and a stronger cash position — factors investors view as supportive of longer?term upside as legalization and demand evolve. TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
• Positive Sentiment: Tilray’s Terrapin Beer Co. unveiled a comprehensive brand refresh aimed at boosting consumer engagement for its craft-beer portfolio — a modest but tangible revenue/brand-strengthening move in the consumer segment. Terrapin Beer Co. Turns Up the Volume with a New Brand Identity
• Neutral Sentiment: Yahoo Finance takes a valuation-focused view, asking whether recent share-price weakness creates a buying opportunity — the piece highlights lower valuation but stresses that execution and margin recovery remain uncertain. Is Tilray Brands (TLRY) Offering Opportunity After Prolonged Share Price Declines
• Neutral Sentiment: Coverage on Tilray Medical Italia notes the company is testing its European medical-cannabis growth thesis in Italy — a potential growth avenue but one that depends on regulatory, distribution and reimbursement execution. Tilray Medical Italia Puts European Cannabis Growth Story To The Test
• Negative Sentiment: The company’s recent quarterly results included a material EPS miss and very weak margins (negative net margin and ROE), which remain the primary near?term headwind and likely explain downward pressure on the share price. Tilray Brands Trading Down (MarketBeat summary)

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on TLRY shares. Atb Cap Markets upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 10th. Canaccord Genuity Group initiated coverage on shares of Tilray Brands in a research report on Tuesday. They issued a “hold” rating on the stock. Roth Mkm decreased their price target on shares of Tilray Brands from $20.00 to $10.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Zacks Research lowered Tilray Brands from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 13th. Finally, Wall Street Zen raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Saturday, October 11th. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Tilray Brands has an average rating of “Reduce” and an average price target of $13.33.

Tilray Brands Stock Performance

The business’s 50-day moving average price is $9.33 and its 200-day moving average price is $10.93. The stock has a market cap of $869.16 million, a PE ratio of -0.34 and a beta of 1.77. The company has a current ratio of 2.81, a quick ratio of 1.72 and a debt-to-equity ratio of 0.19.

Tilray Brands (NASDAQ:TLRY) last issued its quarterly earnings data on Thursday, January 8th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.27). The firm had revenue of $217.51 million during the quarter, compared to analyst estimates of $211.15 million. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.During the same quarter last year, the company posted ($0.03) EPS. As a group, equities research analysts expect that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Oppenheimer & Co. Inc. purchased a new stake in Tilray Brands in the 3rd quarter valued at $25,000. Silverlake Wealth Management LLC acquired a new position in shares of Tilray Brands during the 3rd quarter valued at about $25,000. Unified Investment Management purchased a new stake in shares of Tilray Brands in the third quarter valued at about $26,000. Y Intercept Hong Kong Ltd acquired a new stake in Tilray Brands during the third quarter worth about $30,000. Finally, HighPoint Advisor Group LLC purchased a new position in Tilray Brands during the third quarter worth about $33,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.